206 related articles for article (PubMed ID: 37758273)
1. Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review.
Lo CWH; Pathadka S; Qin SX; Fung LWY; Yan VKC; Yiu HHE; Bloom CI; Wong ICK; Chan EWY
Eur Respir Rev; 2023 Sep; 32(169):. PubMed ID: 37758273
[TBL] [Abstract][Full Text] [Related]
2. Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding.
Apata J; Lyons JG; Bradley MC; Ma Y; Kempner ME; Kim I; Eworuke E; Pennap D; Mosholder A
J Asthma; 2024 Jul; 61(7):653-662. PubMed ID: 38064517
[TBL] [Abstract][Full Text] [Related]
3. Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case-Control Study.
Glockler-Lauf SD; Finkelstein Y; Zhu J; Feldman LY; To T
J Pediatr; 2019 Jun; 209():176-182.e4. PubMed ID: 30905424
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation.
Paljarvi T; Forton J; Luciano S; Herttua K; Fazel S
JAMA Netw Open; 2022 May; 5(5):e2213643. PubMed ID: 35608857
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase(®).
Aldea Perona A; García-Sáiz M; Sanz Álvarez E
Drug Saf; 2016 Jan; 39(1):69-78. PubMed ID: 26620206
[TBL] [Abstract][Full Text] [Related]
6. Risk of Psychiatric Adverse Events Among Montelukast Users.
Sansing-Foster V; Haug N; Mosholder A; Cocoros NM; Bradley M; Ma Y; Pennap D; Dee EC; Toh S; Pestine E; Petrone AB; Kim I; Lyons JG; Eworuke E
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):385-393.e12. PubMed ID: 32795564
[TBL] [Abstract][Full Text] [Related]
7. The Risk of Neuropsychiatric Adverse Events With Use of Leukotriene Receptor Antagonists in Patients With Asthma: Analysis of Korea's National Health Insurance Sharing Service Database.
Kim JH; Lee H; Jeong D; Lee JH; Kwon HS; Song WJ; Cho YS; Kim YJ; Shin YW; Kim TB
J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3690-3699.e7. PubMed ID: 37660732
[TBL] [Abstract][Full Text] [Related]
8. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study.
Ali MM; O'Brien CE; Cleves MA; Martin BC
Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):435-45. PubMed ID: 25683909
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.
Benard B; Bastien V; Vinet B; Yang R; Krajinovic M; Ducharme FM
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28818882
[TBL] [Abstract][Full Text] [Related]
10. Reports of suicidality in clinical trials of montelukast.
Philip G; Hustad C; Noonan G; Malice MP; Ezekowitz A; Reiss TF; Knorr B
J Allergy Clin Immunol; 2009 Oct; 124(4):691-6.e6. PubMed ID: 19815114
[TBL] [Abstract][Full Text] [Related]
11. Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort Study.
Jordan A; Toennesen LL; Eklöf J; Sivapalan P; Meteran H; Bønnelykke K; Ulrik CS; Stæhr Jensen JU
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2096-2103.e1. PubMed ID: 36948487
[TBL] [Abstract][Full Text] [Related]
12. FDA warning montelukast 03.2020-Statement of the Austrian working group of pediatric pulmonology and allergology.
Zschocke A; Horak F; Eber E; Frischer T; Simma B; Stetzl W; Riedler J; Szépfalusi Z; Zacharasiewicz A
Wien Klin Wochenschr; 2022 Jan; 134(1-2):86-88. PubMed ID: 34904177
[TBL] [Abstract][Full Text] [Related]
13. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
Bateman ED; Goehring UM; Richard F; Watz H
J Allergy Clin Immunol; 2016 Jul; 138(1):142-149.e8. PubMed ID: 26915674
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of acupuncture combined montelukast sodium on cough variant asthma in children: A protocol for systematic review and meta-analysis.
Zhou X; Zhang Y; Liu L; Feng X; Zhang H
Medicine (Baltimore); 2021 Dec; 100(51):e28048. PubMed ID: 34941045
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene receptor antagonists for eczema.
Ferguson L; Futamura M; Vakirlis E; Kojima R; Sasaki H; Roberts A; Mori R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011224. PubMed ID: 30343498
[TBL] [Abstract][Full Text] [Related]
16. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
17. Effect of concomitant use of montelukast and efavirenz on neuropsychiatric adverse events.
Ibarra-Barrueta O; Palacios-Zabalza I; Mora-Atorrasagasti O; Mayo-Suarez J
Ann Pharmacother; 2014 Jan; 48(1):145-8. PubMed ID: 24259633
[TBL] [Abstract][Full Text] [Related]
18. Montelukast: a review of its therapeutic potential in persistent asthma.
Jarvis B; Markham A
Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
[TBL] [Abstract][Full Text] [Related]
19. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
Lenney W; McKay AJ; Tudur Smith C; Williamson PR; James M; Price D;
Health Technol Assess; 2013 Feb; 17(4):1-218. PubMed ID: 23380178
[TBL] [Abstract][Full Text] [Related]
20. Pilot Study of Peak Plasma Concentration After High-Dose Oral Montelukast in Children With Acute Asthma Exacerbations.
Arnold DH; Van Driest SL; Reiss TF; King JC; Akers WS
J Clin Pharmacol; 2021 Mar; 61(3):360-367. PubMed ID: 32960980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
